COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2084: Articles 20831-20840  | Next

Modeling the frequency and number of persons to test to detect and control COVID-19 outbreaks in congregate settings
Laws, R. L., Paul, P., Mosites, E., Scobie, H., Clarke, K. E. N., Slayton, R. B.
10.1101/2020.11.20.391011 — Posted: 2020-11-20
The Invasive Respiratory Infection Surveillance (IRIS) Initiative reveals significant reductions in invasive bacterial infections during the COVID-19 pandemic
Brueggemann, A. B., Jansen van Rensburg, M. J., Shaw, D., McCarthy, N. D., Jolley, K. A., Maiden, M. C., van der Linden, M. P.
10.1101/2020.11.18.20225029 — Posted: 2020-11-20
Two independent introductions of SARS-CoV-2 into the Iranian outbreak
Fattahi, Z., Mohseni, M., Jalalvand, K., Aghakhani Moghadam, F., Ghaziasadi, A., Keshavarzi, F., Yavarian, J., Jafarpour, A., Mortazavi, S. e., Ghodratpour, F., Behravan, H., Khazeni, M., Momeni, S. A., Jahanzad, I., Moradi, A., Tabarraei, A., Azimi, S. A., Kord, E., Hashemi-Shahri, S. M., Azaran, A., Yousefi, F., Mokhames, Z., Soleimani, A., Ghafari, S., Ziaee, M., Habibzadeh, S., Jeddi, F., Hadadi, A., Abdollahi, A., Kaydani, G. A., Soltani, S., Mokhtari-Azad, T., Najafipour, R., Malekzadeh, R., Kahrizi, K., Jazayeri, S. M., Najmabadi, H.
10.1101/2020.11.16.20229047 — Posted: 2020-11-20 Discussion: Onsite
AI-Driven Multiscale Simulations Illuminate Mechanisms of SARS-CoV-2 Spike Dynamics
Casalino, L., Dommer, A. C., Gaieb, Z., Barros, E. P., Sztain, T., Ahn, S.-H., Trifan, A., Brace, A., Ma, H., Lee, H., Turilli, M., Bogetti, A., Khalid, S., Chong, L., Simmerling, C., Hardy, D., Maia, J., Phillips, J., Kurth, T., Stern, A., Huang, L., McCalpain, J., Tatineni, M., Gibbs, T., Stone, J. E., Jha, S., Ramanathan, A., Amaro, R. E.
10.1101/2020.11.19.390187 — Posted: 2020-11-20 Discussion: Onsite | Offsite
Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro
Shionoya, K., Yamasaki, M., Iwanami, S., Ito, Y., Fukushi, S., Ohashi, H., Saso, W., Tanaka, T., Aoki, S., Kuramochi, K., Iwami, S., Takahashi, Y., Suzuki, T., Muramatsu, M., Takeda, M., Wakita, T., Watashi, K.
10.1101/2020.11.19.389726 — Posted: 2020-11-20
COVID-19: how the pandemic impacted the emergency department and urgent surgical activity in a medium-size Italian hospital.
Pinotti, E., Carissimi, F., Baronio, G., Montuori, M., Ongaro, D., Ciocca Vasino, M.
10.1101/2020.11.19.20234856 — Posted: 2020-11-20
IMPACT OF THE CORONAVIRUS DISEASE 2019 PANDEMIC ON SURGICAL VOLUME IN JAPAN: A COHORT STUDY USING ADMINISTRATIVE DATA
Okuno, T., Takada, D., Jung-ho, S., Morishita, T., Itoshima, H., Kunisawa, S., Imanaka, Y.
10.1101/2020.11.18.20233882 — Posted: 2020-11-20
Impact of the home confinement related to COVID-19 on the device-assessed physical activity and sedentary patterns of Spanish older adults
Fernandez-Garcia, A. I., Marin-Puyalto, J., Gomez-Cabello, A. M., Matute-Llorente, A., Subias-Perie, J., Perez-Gomez, J., Lozano-Berges, G., Manas, A., Guadalupe-Grau, A., Gonzalez-Gross, M., Ara, I., Casajus, J. A., Vicente-Rodriguez, G.
10.1101/2020.11.19.20234583 — Posted: 2020-11-20
Clinical evaluation of the Roche/SD Biosensor rapid antigen test with symptomatic, non-hospitalized patients in a municipal health service drive-through testing site.
Igloi, Z., Velzing, J., van Beek, J., van de Vijver, D., Aron, G., Ensing, R., Benschop, K., Han, W., Boelsums, T., Koopmans, M., Geurtsvankessel, C., Molenkamp, R.
10.1101/2020.11.18.20234104 — Posted: 2020-11-20 Discussion: Onsite
A network modelling approach to assess non-pharmaceutical disease controls in a worker population: An application to SARS-CoV-2
Hill, E. M., Atkins, B. D., Keeling, M. J., Dyson, L., Tildesley, M. J.
10.1101/2020.11.18.20230649 — Posted: 2020-11-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).